Speaker illustration

Assistant Professor Mohammad Kermani-Alghoraishi

Isfahan Interventional Cardiology Research Center, Isfahan (Iran (Islamic Republic of))

Member of:


Does allopurinol improve inflammatory biomarkers and post-revascularization coronary blood flow in Non-STEMI patients?

Event: ESC Preventive Cardiology 2022

Topic: Revascularisation

Session: ePosters


Allopurinol pretreatment effects on coronary blood flow and revascularization outcomes in acute STEMI patients underwent emergency percutaneous coronary intervention

Event: ESC Acute CardioVascular Care 2022

Topic: Revascularisation

Session: e-Posters session


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb